Search Results for 'egfr'

egfr published presentations and documents on DocSlides.

A Primary Care Approach to CKD Management
A Primary Care Approach to CKD Management
by myesha-ticknor
Learning Objectives. Facilitate timely testing an...
Systolic Blood Pressure Intervention Trial (SPRINT)
Systolic Blood Pressure Intervention Trial (SPRINT)
by pamella-moone
Principal Results. Paul K. Whelton, MB, MD, MSc. ...
NCI-Molecular Analysis for Therapy Choice
NCI-Molecular Analysis for Therapy Choice
by phoebe-click
(NCI-MATCH or EAY131). Interim Analysis Results....
High Impact Publication
High Impact Publication
by yoshiko-marsland
. Steven B. Maron. , Lindsay Alpert, . Heewon. ...
Analytical Team Faye Cleary
Analytical Team Faye Cleary
by phoebe-click
Lois Kim. Dr Sally Hull. Dr . Ben Caplin. Profess...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
Renal Replacement Therapy: What the PCP Needs to Know
Renal Replacement Therapy: What the PCP Needs to Know
by tatiana-dople
Learning Objectives. Describe treatment options f...
Systolic Blood Pressure Intervention Trial (SPRINT)
Systolic Blood Pressure Intervention Trial (SPRINT)
by lois-ondreau
Principal Results. Paul K. Whelton, MB, MD, MSc. ...
Pharmacologic Approaches to Treating CKD in Type 2 DM (1)
Pharmacologic Approaches to Treating CKD in Type 2 DM (1)
by calandra-battersby
Metformin must be considered the cornerstone of t...
The direct oral anticoagulants (DOACs)
The direct oral anticoagulants (DOACs)
by faustina-dinatale
and major trauma. Dr. Tina . Biss. Consultant . ...
Chris Dobson Renal disease: AKI vs CKD
Chris Dobson Renal disease: AKI vs CKD
by kittie-lecroy
What is acute kidney injury (AKI). Hyperkalaemia....
Canadian Diabete
Canadian Diabete
by trish-goza
s Association Clinical Practice Guidelines. Treat...
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...
Molecular Subtypes:
Molecular Subtypes:
by giovanna-bartolotta
Not Quite Ready . for Prime Time. Scott Kopetz, M...
Switch to DRV/r + RAL
Switch to DRV/r + RAL
by debby-jeon
SPARE . Study. SPARE Study: switch to DRV/r + RAL...
LIFE Study: Lower Systolic Pressure Slowed Progression of R
LIFE Study: Lower Systolic Pressure Slowed Progression of R
by phoebe-click
in . Hypertension. From ESH 2016 | POS 4C:. Sverr...
Chronic Kidney Disease 101
Chronic Kidney Disease 101
by phoebe-click
Nutrition Intervention. Identify chronic kidney d...
Assessing Renal Patients
Assessing Renal Patients
by phoebe-click
Sharondeep. Gill. Overview. Chronic Kidney Disea...
Obstructive Sleep
Obstructive Sleep
by phoebe-click
Apnoea. (OSA) Predicts . Microvascular. Complic...
Class 12 DNA sequencing and cancer
Class 12 DNA sequencing and cancer
by tatyana-admore
DNA pol error rate . ~. 10. -9. per base . copie...
Cost of & Access to
Cost of & Access to
by kittie-lecroy
Molecularly Targeted Therapies as Barriers to Opt...
Targeting KRAS and down streaming
Targeting KRAS and down streaming
by alexa-scheidler
pathways. Federico Cappuzzo. Istituto Toscano Tum...
Terapia
Terapia
by min-jolicoeur
targeted. : . limiti e successi nelle metastasi ...
Department of GI Medical Oncology
Department of GI Medical Oncology
by danika-pritchard
Does . the New EPOC trial . eliminate. . Anti. -...
Serum
Serum
by conchita-marotz
Creatinine. . and . eGFR. . Where . A. re . W. ...
Chee Lee,
Chee Lee,
by olivia-moreira
MBBS (Hons), . MMedSci. (. Clin. . Epid. ), . M...
P2Y2
P2Y2
by giovanna-bartolotta
Agonist Promotes . Corneal . Epithelial Wou...
David R.
David R.
by alida-meadow
Gandara. , MD. University of California, Davis . ...